NextPlat (NXPL) Accounts Payables (2010 - 2026)
NextPlat's (NXPL) quarterly Accounts Payables came in at $10.3 million in Q2 2026, up 96.66% year-over-year from $5.2 million in Q2 2025, and up 22.81% quarter-over-quarter from $8.3 million in Q1 2026.
Analysis
NextPlat (NXPL) Accounts Payables (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Accounts Payables for 17 consecutive years, with $10.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables rose 96.66% year-over-year to $10.3 million in Q2 2026; TTM through Jun 2026 was $10.3 million, a 96.66% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 14.32% from the prior year.
- Accounts Payables was $10.3 million for Q2 2026 at NextPlat, up from $8.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $14.9 million in Q1 2024 and troughed at $1.1 million in Q2 2022.
- A 5-year average of $6.9 million and a median of $7.4 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables soared 1158.52% in 2023 and slumped 56.17% in 2025, its largest moves.
- Over 5 years, Accounts Payables stood at $1.5 million in 2022, then jumped by 765.13% to $13.2 million in 2023, then sank by 45.13% to $7.2 million in 2024, then increased by 14.32% to $8.3 million in 2025, then rose by 24.04% to $10.3 million in 2026.
- The last three Accounts Payables figures came in at $10.3 million (Q2 2026), $8.3 million (Q1 2026), and $8.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 2.72 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.73 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 396.07 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 721.21 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 593.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 73.83 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 133.16 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 251.37 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 5.52 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 10.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.25 Mn |
| Mar 31, 2026 | 8.35 Mn |
| Dec 31, 2025 | 8.27 Mn |
| Sep 30, 2025 | 6.44 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 7.50 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 11.89 Mn |
| Mar 31, 2024 | 14.89 Mn |
| Dec 31, 2023 | 13.18 Mn |
| Sep 30, 2023 | 13.68 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 884,046.00 |